Patents by Inventor Dorte Strobaek

Dorte Strobaek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL POTASSIUM CHANNEL INHIBITORS
    Publication number: 20240368077
    Abstract: The present invention relates to novel compounds, pharmaceutical compositions comprising such compounds and their use for treating, alleviating or preventing diseases or disorders relating to the activity of potassium channels.
    Type: Application
    Filed: May 2, 2024
    Publication date: November 7, 2024
    Inventors: David Tristram BROWN, Palle CHRISTOPHERSEN, Thomas Amos JACOBSEN, Janus S. LARSEN, Pernille Hartveit Poulsen, Dorte STRØBAEK
  • POTASSIUM CHANNEL MODULATORS
    Publication number: 20240317705
    Abstract: Provided are novel compounds of Formula (I): and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions which can be affected by potassium channel modulation. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with potassium channels.
    Type: Application
    Filed: August 11, 2023
    Publication date: September 26, 2024
    Inventors: Birgitte Langer Eriksen, Magnus Gustafsson, Charlotte Hougaard, Thomas Amos Jacobsen, Martin R. Jefson, Gregg F. Keaney, Jessica Klein, Janus Schreiber Larsen, John A. Lowe, III, John M. McCall, Dorte Strøbæk, Nadia Lybøl von Schoubye
  • Potassium channel inhibitors
    Patent number: 12006289
    Abstract: The present invention relates to novel compounds, pharmaceutical compositions comprising such compounds and their use for treating, alleviating or preventing diseases or disorders relating to the activity of potassium channels.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: June 11, 2024
    Assignee: Saniona A/S
    Inventors: David Tristram Brown, Palle Christophersen, Thomas Amos Jacobsen, Janus S. Larsen, Pernille Hartveit Poulsen, Dorte Strøbaek
  • NOVEL POTASSIUM CHANNEL INHIBITORS
    Publication number: 20240034717
    Abstract: The present invention relates to novel compounds, pharmaceutical compositions comprising such compounds and their use for treating, alleviating or preventing diseases or disorders relating to the activity of potassium channels.
    Type: Application
    Filed: September 21, 2021
    Publication date: February 1, 2024
    Inventors: David Tristram BROWN, Palle CHRISTOPHERSEN, Thomas Amos JACOBSEN, Janus S. LARSEN, Pernille Hartveit POULSEN, Dorte STRØBAEK
  • NOVEL POTASSIUM CHANNEL INHIBITORS
    Publication number: 20220169602
    Abstract: The present invention relates to novel compounds, pharmaceutical compositions comprising such compounds and their use for treating, alleviating or preventing diseases or disorders relating to the activity of potassium channels.
    Type: Application
    Filed: March 20, 2020
    Publication date: June 2, 2022
    Inventors: David Tristram BROWN, Palle CHRISTOPHERSEN, Thomas Amos JACOBSEN, Janus S. LARSEN, Pernille Hartveit Poulsen, Dorte STRØBAEK
  • Potassium channel modulators
    Patent number: 10774064
    Abstract: Provided are novel compounds of Formula (I): and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions which can be affected by potassium channel modulation. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with potassium channels.
    Type: Grant
    Filed: June 2, 2017
    Date of Patent: September 15, 2020
    Assignee: Cadent Therapeutics, Inc.
    Inventors: Birgitte Langer Eriksen, Magnus Gustafsson, Charlotte Hougaard, Thomas Amos Jacobsen, Martin R. Jefson, Gregg F. Keaney, Jessica Klein, Janus Schreiber Larsen, John A. Lowe, III, John M. McCall, Dorte Strøbæk, Nadia Lybøl von Schoubye
  • POTASSIUM CHANNEL MODULATORS
    Publication number: 20190218200
    Abstract: Provided are novel compounds of Formula (I): and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions which can be affected by potassium channel modulation. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with potassium channels.
    Type: Application
    Filed: June 2, 2017
    Publication date: July 18, 2019
    Inventors: Birgitte Langer Eriksen, Magnus Gustafsson, Charlotte Hougaard, Thomas Amos Jacobsen, Martin R. Jefson, Gregg F. Keaney, Jessica Klein, Janus Schreiber Larsen, John A. Lowe, III, John M. McCall, Dorte Strøbæk, Nadia Lybøl von Schoubye
  • Substituted [1,2,4]triazolo[1,5-a]pyrimidines and their use as potassium channel modulators
    Patent number: 8685987
    Abstract: This invention relates to novel substituted [1,2,4]triazolo[1,5-a]pyrimidines and their use as modulators of potassium channels. In other aspects the invention relates to the use of these compounds, in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
    Type: Grant
    Filed: March 30, 2010
    Date of Patent: April 1, 2014
    Assignee: Ataxion, Inc.
    Inventors: Ulrik Svane Sørensen, Birgitte L. Eriksen, Charlotte Hougaard, Dorte Strøbæk, Palle Christophersen
  • 2, 3, 6 - TRIAMINO SUBSTITUTED PYRIDINES AS KV7 (KCNQ) CHANNEL MODULATORS
    Publication number: 20120238547
    Abstract: The present application relates to novel substituted aminopyridine derivatives, to their use in therapy, to pharmaceutical compositions comprising the derivatives, to the use of said derivatives in the manufacture of a medicament, and to therapeutic methods comprising the administration of the derivatives. The present derivatives are useful for treating a disorder responsive to activation of Kv7 channels.
    Type: Application
    Filed: September 2, 2010
    Publication date: September 20, 2012
    Applicant: NEUROSEARCH A/S
    Inventors: William Dalby Brown, Carsten Jessen, Dorte Strøbæk
  • SUBSTITUTED PYRIDINE DERIVATIVES AND THEIR MEDICAL USE
    Publication number: 20120232058
    Abstract: The present application relates to novel substituted pyridine derivatives, to their use in therapy, to pharmaceutical compositions comprising the derivatives, to the use of said derivatives in the manufacture of a medicament, and to therapeutic methods comprising the administration of the derivatives. The present derivatives are useful for treating a disorder responsive to activation of Kv7 channels. Formula (I).
    Type: Application
    Filed: September 2, 2010
    Publication date: September 13, 2012
    Applicant: NEUROSEARCH A/S
    Inventors: William Dalby Brown, Carsten Jessen, Dorte Strøbæk
  • 2, 3-diamino-quinazolinone derivatives and their medical use
    Patent number: 8178544
    Abstract: This invention provides 2,3-diamino-quinazolinone compounds of Formula (I) stereoisomers thereof, pharmaceutically-acceptable addition salts thereof, and N-oxides thereof, wherein the variables are as defined in the specification. The 2,3-diamino-quinazolinone compounds have medical utility. The 2,3-diamino-quinazolinone compounds can be used for the manufacture of medicaments, including pharmaceutical compositions. This invention also provides methods of treating disorders, diseases, or conditions which are responsive to activation of Kv7 channels.
    Type: Grant
    Filed: May 22, 2008
    Date of Patent: May 15, 2012
    Assignee: Neurosearch A/S
    Inventors: Carsten Jessen, William Dalby Brown, Joachim Demnitz, Dorte Strøbæk, Mads P. G. Korsgaard, Palle Christophersen
  • SUBSTITUTED NAPHTHYRIDINE DERIVATIVES AND THEIR MEDICAL USE
    Publication number: 20120115900
    Abstract: The present application discloses novel substituted naphthyridine derivatives of Formula (I) and their use as modulators of the voltage gated Kv7 (KCNQ) potassium ion channels. In other aspects the application discloses the use of these compounds, in a method for therapy and to pharmaceutical compositions comprising these compounds.
    Type: Application
    Filed: April 21, 2010
    Publication date: May 10, 2012
    Applicant: NEUROSEARCH A/S
    Inventors: William Dalby Brown, Carsten Jessen, Cecilia Mattsson, Richard Sott, Dorte Strøbæk
  • SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
    Publication number: 20120101112
    Abstract: This invention relates to novel substituted [1,2,4]triazolo[1,5-a]pyrimidines and their use as modulators of potassium channels. In other aspects the invention relates to the use of these compounds, in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
    Type: Application
    Filed: March 30, 2010
    Publication date: April 26, 2012
    Applicant: NEUROSEARCH A/S
    Inventors: Ulrik Svane Sørensen, Birgitte L. Eriksen, Charlotte Hougaard, Dorte Strøbæk, Palle Christophersen
  • SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
    Publication number: 20120095025
    Abstract: This invention relates to novel substituted [1,2,4]triazolo[1,5-a]pyrimidines useful as modulators of potassium channels. In other aspects the invention relates to the use of these compounds, in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention. Formula (I).
    Type: Application
    Filed: March 30, 2010
    Publication date: April 19, 2012
    Applicant: NEUROSEARCH A/S
    Inventors: Ulrik Svane Sørensen, Birgitte L. Eriksen, Dorte Strøbæk, Palle Christophersen
  • SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
    Publication number: 20120088780
    Abstract: This invention relates to novel substituted [1,2,4]triazolo[1,5-a]pyrimidines and their use as modulators of potassium channels. In other aspects the invention relates to the use of these compounds, in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
    Type: Application
    Filed: March 30, 2010
    Publication date: April 12, 2012
    Applicant: NEUROSEARCH A/S
    Inventors: Ulrik Svane Sørensen, Birgitte L. Eriksen, Charlotte Hougaard, Dorte Strøbaek, Palle Christophersen
  • SUBSTITUTED PYRIDINE DERIVATIVES AND THEIR MEDICAL USE
    Publication number: 20120059037
    Abstract: The present application discloses novel substituted pyridinyl-methylamine derivatives and their use as modulators of the voltage gated Kv7 (KCNQ) potassium ion channels. In other aspects the application discloses the use of these compounds, in a method for therapy and to pharmaceutical compositions comprising these compounds.
    Type: Application
    Filed: March 11, 2010
    Publication date: March 8, 2012
    Applicant: NEUROSEARCH A/S
    Inventors: Carsten Jessen, William Dalby Brown, Dorte Strøbæk
  • NOVEL 2-MORPHOLINO-3-AMIDO-PYRIDINE DERIVATIVES AND THEIR MEDICAL USE
    Publication number: 20110312962
    Abstract: The present application discloses novel 2-morpholino-3-amido-pyhcline derivatives and their use as modulators of the voltage gated Kv7 (KCNQ) potassium ion channels in the treatment of pain, neurodegenerative disorders, urinary incontinence, etc. . . . . In other aspects the application discloses the use of these compounds, in a method for therapy and to pharmaceutical compositions comprising these compounds.
    Type: Application
    Filed: November 26, 2009
    Publication date: December 22, 2011
    Applicant: NEUROSEARCH A/S
    Inventors: William Dalby Brown, Carsten Jessen, Dorte Strøbaek
  • NOVEL 2,3-DIAMINO-QUINAZOLINONE DERIVATIVES AND THEIR MEDICAL USE
    Publication number: 20110269783
    Abstract: The present invention relates to novel 2,3-diamino-quinazolinone derivatives having medical utility, to use of the derivatives for the manufacture of a medicament, to pharmaceutical compositions comprising the derivatives, and to methods of treating a disorder, disease or a condition responsive to activation of Kv7 channels.
    Type: Application
    Filed: November 6, 2009
    Publication date: November 3, 2011
    Applicant: NEUROSEARCH A/S
    Inventors: Carsten Jessen, William Dalby Brown, Dorte Strøbaek
  • Guanidine derivatives and their medical use
    Patent number: 8048877
    Abstract: This invention relates to novel guanidine derivatives useful as modulators of small-conductance calcium-activated potassium channels (SK channels). In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
    Type: Grant
    Filed: March 22, 2007
    Date of Patent: November 1, 2011
    Assignee: Neurosearch A/S
    Inventors: Ulrik Svane Sørensen, Birgitte L. Eriksen, Lene Teuber, Dan Peters, Dorte Strøbæk, Tina Holm Johansen, Palle Christophersen
  • 2-aminio-pyridine derivatives and their use as potassium channel modulators
    Patent number: 8039632
    Abstract: This invention relates to novel 2-amino-pyridine derivative useful as modulators of small-conductance calcium-activated potassium channels (SK channels). In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
    Type: Grant
    Filed: November 12, 2007
    Date of Patent: October 18, 2011
    Assignee: Neurosearch A/S
    Inventors: Ulrik Svane Sørensen, Birgitte L. Eriksen, Lene Teuber, Dan Peters, Dorte Strøbæk, Tina Holm Johansen, Palle Christophersen